United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Oct 15, 2026 · Filed Oct 16, 2026

On Oct 15, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$544.30 for US$4.52M under a trading plan, leaving 45,172 shares. Filed Oct 16, 2026 (Form 4).

Sold
8,300 shares
Price
US$544.30 average (US$541.64 to US$546.56)
Value
US$4.52M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 15, 2026Common StockOption exercise8,300US$146.0353,472Direct
Oct 15, 2026Common StockSale268US$541.6453,204Direct
Oct 15, 2026Common StockSale1,924US$542.4951,280Direct
Oct 15, 2026Common StockSale1,983US$543.5649,297Direct
Oct 15, 2026Common StockSale791US$544.8548,506Direct
Oct 15, 2026Common StockSale2,615US$545.6945,891Direct
Oct 15, 2026Common StockSale719US$546.5645,172Direct

Source

Download original · View original at SEC

Related